These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Isolevuglandins Promote Mitochondrial Dysfunction and Electrophysiologic Abnormalities in Atrial Cardiomyocytes. Subati T; Yang Z; Murphy MB; Stark JM; Trykall DZ; Davies SS; Barnett JV; Murray KT Cells; 2024 Mar; 13(6):. PubMed ID: 38534327 [TBL] [Abstract][Full Text] [Related]
3. 2-Hydroxybenzylamine (2-HOBA) to prevent early recurrence of atrial fibrillation after catheter ablation: protocol for a randomized controlled trial including detection of AF using a wearable device. O'Neill MJ; Yoneda ZT; Crawford DM; Ye F; Ao M; Pitchford LM; Rathmacher JA; Murray KT; Akers WS; Roden DM; Michaud GF; Shoemaker MB Trials; 2021 Aug; 22(1):576. PubMed ID: 34454591 [TBL] [Abstract][Full Text] [Related]
10. Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr Tao H; Huang J; Yancey PG; Yermalitsky V; Blakemore JL; Zhang Y; Ding L; Zagol-Ikapitte I; Ye F; Amarnath V; Boutaud O; Oates JA; Roberts LJ; Davies SS; Linton MF Nat Commun; 2020 Aug; 11(1):4084. PubMed ID: 32796843 [TBL] [Abstract][Full Text] [Related]
11. IsoLGs (Isolevuglandins) Drive Neutrophil Migration in Hypertension and Are Essential for the Formation of Neutrophil Extracellular Traps. Krishnan J; de la Visitación N; Hennen EM; Amarnath V; Harrison DG; Patrick DM Hypertension; 2022 Aug; 79(8):1644-1655. PubMed ID: 35686559 [TBL] [Abstract][Full Text] [Related]
12. Targeting of reactive isolevuglandins in mitochondrial dysfunction and inflammation. Mayorov V; Uchakin P; Amarnath V; Panov AV; Bridges CC; Uzhachenko R; Zackert B; Moore CS; Davies S; Dikalova A; Dikalov S Redox Biol; 2019 Sep; 26():101300. PubMed ID: 31437812 [TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Isolevuglandins Contribute to Vascular Oxidative Stress and Mitochondria-Targeted Scavenger of Isolevuglandins Reduces Mitochondrial Dysfunction and Hypertension. Dikalova A; Mayorov V; Xiao L; Panov A; Amarnath V; Zagol-Ikapitte I; Vergeade A; Ao M; Yermalitsky V; Nazarewicz RR; Boutaud O; Lopez MG; Billings FT; Davies S; Roberts LJ; Harrison DG; Dikalov S Hypertension; 2020 Dec; 76(6):1980-1991. PubMed ID: 33012204 [TBL] [Abstract][Full Text] [Related]
14. Biomarkers for predicting atrial fibrillation: An explorative sub-analysis of the randomised SCREEN-AF trial. Schmalstieg-Bahr K; Gladstone DJ; Hummers E; Suerbaum J; Healey JS; Zapf A; Köster D; Werhahn SM; Wachter R Eur J Gen Pract; 2024 Dec; 30(1):2327367. PubMed ID: 38497412 [TBL] [Abstract][Full Text] [Related]
15. Electrophilic reactive aldehydes as a therapeutic target in colorectal cancer prevention and treatment. Gobert AP; Asim M; Smith TM; Williams KJ; Barry DP; Allaman MM; McNamara KM; Hawkins CV; Delgado AG; Zhao S; Piazuelo MB; Washington MK; Coburn LA; Rathmacher JA; Wilson KT Oncogene; 2023 May; 42(20):1685-1691. PubMed ID: 37037901 [TBL] [Abstract][Full Text] [Related]
16. Hypertension is associated with preamyloid oligomers in human atrium: a missing link in atrial pathophysiology? Sidorova TN; Mace LC; Wells KS; Yermalitskaya LV; Su PF; Shyr Y; Atkinson JB; Fogo AB; Prinsen JK; Byrne JG; Petracek MR; Greelish JP; Hoff SJ; Ball SK; Glabe CG; Brown NJ; Barnett JV; Murray KT J Am Heart Assoc; 2014 Dec; 3(6):e001384. PubMed ID: 25468655 [TBL] [Abstract][Full Text] [Related]
17. Isolevuglandins (isoLGs) as toxic lipid peroxidation byproducts and their pathogenetic role in human diseases. Aschner M; Nguyen TT; Sinitskii AI; Santamaría A; Bornhorst J; Ajsuvakova OP; da Rocha JBT; Skalny AV; Tinkov AA Free Radic Biol Med; 2021 Jan; 162():266-273. PubMed ID: 33099003 [TBL] [Abstract][Full Text] [Related]
18. Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP - A narrative review. Kerr B; Brandon L Int J Cardiol Heart Vasc; 2022 Dec; 43():101132. PubMed ID: 36246770 [TBL] [Abstract][Full Text] [Related]
19. Isolevuglandins disrupt PU.1-mediated C1q expression and promote autoimmunity and hypertension in systemic lupus erythematosus. Patrick DM; de la Visitación N; Krishnan J; Chen W; Ormseth MJ; Stein CM; Davies SS; Amarnath V; Crofford LJ; Williams JM; Zhao S; Smart CD; Dikalov S; Dikalova A; Xiao L; Van Beusecum JP; Ao M; Fogo AB; Kirabo A; Harrison DG JCI Insight; 2022 Jul; 7(13):. PubMed ID: 35608913 [TBL] [Abstract][Full Text] [Related]
20. Immunoproteasomal Processing of Isolevuglandin Adducts in Hypertension. de la Visitación N; Chen W; Krishnan J; Van Beusecum JP; Amarnath V; Hennen EM; Zhao S; Saleem M; Ao M; Harrison DG; Patrick DM bioRxiv; 2023 Apr; ():. PubMed ID: 37383945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]